Solid biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

Charlestown, mass., may 01, 2025 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 81,000 restricted stock units (“rsus”) to seven newly hired employees.

NDAQ Ratings Summary

NDAQ Quant Ranking